Articles

• Evaluation of safety and efficacy of levodopa in Parkinson's disease and syndromeResults of a collaborative study

  Harrison M. Langrall, Clifford Joseph

  • Full Text (PDF)
• Thirty months' trial of levodopa in Parkinson's disease

  Charles H. Markham

  • Full Text (PDF)
• Long‐term appraisal of levodopa therapy

  André Barbeau

  • Full Text (PDF)
• Panel discussionLong‐term safety and efficacy of levodopa

  C. H. Markham, A. Barbeau, H. M. Langrall, F. McDowell, M. D. Yahr

  • Full Text (PDF)
• Levodopa and surgical anesthesia

  S. H. Ngai, Richard A. Wiklund

  • Full Text (PDF)
• Levodopa and behavior

  Manuel Riklan

  • Full Text (PDF)
• Autopsy findings in parkinsonism following treatment with levodopa

  Melvin D. Yahr, Abner Wolf, Joao-Lobo Antunes, Koho Miyoshi, Philip Duffy

  • Full Text (PDF)
• Effects of levodopa on nondopaminergic brain neurons

  R. J. Wurtman, J. A. Romero

  • Full Text (PDF)
• Some newer metabolic concepts in the treatment of parkinsonism

  George C. Cotzias, Paul S. Papavasiliou, Simone E. Düby, Andreas J. Steck, James Z. Ginos

  • Full Text (PDF)
• Levodopa and cholinergic hypersensitivity in Parkinson's disease

  Melvin H. Van Woert, Lalit Ambani, Malcolm B. Bowers

  • Full Text (PDF)
• Mechanism of actionPanel discussion

  S. Spector, B. B. Brodie, G. C. Cotzias, Van Woert, R. J. Wurtman

  • Full Text (PDF)